Human Immune Response to a Plague Vaccine Comprising Recombinant F1 and V Antigens

The human immune response to a new recombinant plague vaccine, comprising recombinant F1 (rF1) and rV antigens, has been assessed during a phase 1 safety and immunogenicity trial in healthy volunteers. All the subjects produced specific immunoglobulin G (IgG) in serum after the priming dose, which p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Williamson, E. D., Flick-Smith, H. C., LeButt, C., Rowland, C. A., Jones, S. M., Waters, E. L., Gwyther, R. J., Miller, J., Packer, P. J., Irving, M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Microbial Immunity and Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1111881/
https://ncbi.nlm.nih.gov/pubmed/15908389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.73.6.3598-3608.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados